Anaes SAQs · Regional anaesthesia
Upper limb regional anaesthesia: brachial plexus approaches
Final-examination SAQ for upper-limb-regional-blocks.
On this page
Study tools
Target exams
Model answer
Framing. Match the brachial plexus approach to surgical territory: interscalene for shoulder (accept phrenic block — classically 100 percent paresis, cut to 13 percent by low-dose ultrasound technique at C7), supraclavicular for arm/forearm with pneumothorax risk, infraclavicular for below-elbow work and catheters (higher success than supraclavicular, OR 0.61, with less diaphragmatic risk), axillary for the hand with the musculocutaneous blocked separately; use ultrasound, dose limits, and ASRA LAST rescue with lipid emulsion per protocol[1][4][5][6].
Must cover.
- Anatomy of brachial plexus roots trunks divisions cords branches (standard teaching; approach comparisons trial-owned)[4]
- Interscalene indications and phrenic nerve paresis (Petrar: complete paresis 34 percent supraclavicular vs 3 percent infraclavicular; Renes: 13 vs 93 percent ultrasound vs nerve-stimulation interscalene)[5][6]
- Supraclavicular vs infraclavicular vs axillary decision matrix (Muir 18 RCTs, 1389 patients: infraclavicular higher success)[4]
- Ultrasound technique principles and LA dose limits (trial arms: 30 mL 0.5 percent ropivacaine SC vs IC; 15 mL 0.5 percent single vs multiple-point; 10 mL 0.75 percent low-dose interscalene; ceilings per formulary)[5][6][7]
- LAST prevention and lipid-emulsion rescue per protocol (ASRA advisory: ultrasound prevention, delayed-presentation trend, small-size/sarcopenia risk; lipid 1.5 mL/kg lean body weight)[1]
- Anticoagulation considerations for deep blocks (ASRA fourth-edition drug-specific timing)[2]
- Catheter techniques and continuous infusions (per local protocol)[2]
- Failed block rescue strategy (Mangal: single-point success 60.8 vs 98 percent multiple-point; convert rather than stack to toxicity)[7]
Crisis. LAST after interscalene or supraclavicular block — stop injection, airway with 100 percent oxygen, benzodiazepine for seizures, lipid 1.5 mL/kg bolus then infusion, prolonged CPR with reduced adrenaline doses[1].
High-yield numbers/facts. Lipid 1.5 mL/kg lean body weight bolus (ASRA); complete hemidiaphragm paresis 34 vs 3 percent SC vs IC (Petrar); 13 vs 93 percent US vs nerve-stim interscalene (Renes); single- vs multiple-point success 60.8 vs 98 percent (Mangal); infra- vs supraclavicular success OR 0.61 (Muir)[1][4][5][6][7].
References7ShowHide
- [1]Neal JM, Barrington MJ, Fettiplace MR, et al. The Third American Society of Regional Anesthesia and Pain Medicine Practice Advisory on Local Anesthetic Systemic Toxicity: Executive Summary 2017. Regional Anesthesia and Pain Medicine, 2018.PMID 29356773
- [2]Horlocker TT, Vandermeuelen E, Kopp SL, et al. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition). Regional Anesthesia and Pain Medicine, 2018.PMID 29561531
- [3]Frerk C, Mitchell VS, McNarry AF, et al. Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. British Journal of Anaesthesia, 2015.PMID 26556848
- [4]Muir D, Cara J, Morris R, et al. Supraclavicular versus infraclavicular brachial plexus block in upper limb orthopaedic surgery: a systematic review and meta-analysis of randomised controlled trials. European Journal of Orthopaedic Surgery and Traumatology, 2024.PMID 39287814
- [5]Petrar SD, Seltenrich ME, Head SJ, Schwarz SK Hemidiaphragmatic paralysis following ultrasound-guided supraclavicular versus infraclavicular brachial plexus blockade: a randomized clinical trial. Regional Anesthesia and Pain Medicine, 2015.PMID 25650633
- [6]Renes SH, Rettig HC, Gielen MJ, et al. Ultrasound-guided low-dose interscalene brachial plexus block reduces the incidence of hemidiaphragmatic paresis. Regional Anesthesia and Pain Medicine, 2009.PMID 19920426
- [7]Mangal V, Meena C, Meena K, et al. Comparison of USG-Guided Supraclavicular Brachial Plexus Block by Single-Point Versus Multiple-Point Injection Technique: A Prospective Randomized Trial. Cureus, 2023.PMID 38111430